U.S. markets open in 9 hours 17 minutes
  • S&P Futures

    4,006.50
    +3.25 (+0.08%)
     
  • Dow Futures

    34,021.00
    +35.00 (+0.10%)
     
  • Nasdaq Futures

    11,805.50
    -0.25 (-0.00%)
     
  • Russell 2000 Futures

    1,843.60
    +1.70 (+0.09%)
     
  • Crude Oil

    77.27
    +0.34 (+0.44%)
     
  • Gold

    1,783.90
    +2.60 (+0.15%)
     
  • Silver

    22.34
    +0.14 (+0.64%)
     
  • EUR/USD

    1.0493
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    3.5990
    +0.0930 (+2.65%)
     
  • Vix

    20.75
    +1.69 (+8.87%)
     
  • GBP/USD

    1.2192
    -0.0002 (-0.02%)
     
  • USD/JPY

    136.8660
    +0.1810 (+0.13%)
     
  • BTC-USD

    17,014.35
    -353.37 (-2.03%)
     
  • CMC Crypto 200

    401.90
    -9.32 (-2.27%)
     
  • FTSE 100

    7,567.54
    +11.31 (+0.15%)
     
  • Nikkei 225

    27,903.24
    +82.84 (+0.30%)
     

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

In the past two years, biotech companies Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) rose to fame thanks to their successful attempts to develop vaccines for COVID-19 and help us end the outbreak. The pandemic isn't over yet, but Moderna and Novavax have given up substantial chunks of their value in the past year. Where does that leave Moderna and Novavax?